Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.74
-0.02 (-0.17%)
Mar 17, 2025, 2:33 PM EDT - Market open
Amneal Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 17, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,708 | 2,454 | 1,861 | 301 | 715 | 675 | Upgrade
|
| Market Cap Growth | 31.88% | 31.88% | 517.28% | -57.87% | 6.05% | 4.38% | Upgrade
|
| Enterprise Value | 5,193 | 5,081 | 4,434 | 2,989 | 3,372 | 3,471 | Upgrade
|
| Last Close Price | 8.75 | 7.92 | 6.07 | 1.99 | 4.79 | 4.57 | Upgrade
|
| PE Ratio | - | - | - | - | 67.35 | 7.41 | Upgrade
|
| Forward PE | 12.81 | 11.68 | 11.92 | 2.71 | 5.65 | 7.07 | Upgrade
|
| PS Ratio | 0.97 | 0.88 | 0.78 | 0.14 | 0.34 | 0.34 | Upgrade
|
| PB Ratio | -60.90 | -55.10 | 30.35 | 1.44 | 1.86 | 1.89 | Upgrade
|
| P/FCF Ratio | 11.55 | 10.45 | 6.23 | 18.49 | 3.75 | 2.13 | Upgrade
|
| P/OCF Ratio | 9.19 | 8.32 | 5.38 | 4.63 | 2.96 | 1.78 | Upgrade
|
| PEG Ratio | 0.51 | 0.51 | 0.51 | 0.18 | 0.66 | 2.65 | Upgrade
|
| EV/Sales Ratio | 1.86 | 1.82 | 1.85 | 1.35 | 1.61 | 1.74 | Upgrade
|
| EV/EBITDA Ratio | 8.88 | 8.69 | 8.85 | 6.79 | 7.49 | 9.11 | Upgrade
|
| EV/EBIT Ratio | 14.91 | 14.59 | 16.34 | 14.94 | 15.57 | 23.83 | Upgrade
|
| EV/FCF Ratio | 22.12 | 21.64 | 14.84 | 183.29 | 17.67 | 10.94 | Upgrade
|
| Debt / Equity Ratio | -58.22 | -58.22 | 44.87 | 13.62 | 7.52 | 8.41 | Upgrade
|
| Debt / EBITDA Ratio | 4.28 | 4.28 | 5.26 | 6.15 | 6.15 | 7.36 | Upgrade
|
| Debt / FCF Ratio | 11.05 | 11.05 | 9.21 | 174.49 | 15.13 | 9.46 | Upgrade
|
| Asset Turnover | 0.80 | 0.80 | 0.66 | 0.57 | 0.53 | 0.52 | Upgrade
|
| Inventory Turnover | 2.98 | 2.98 | 2.75 | 2.79 | 2.67 | 3.07 | Upgrade
|
| Quick Ratio | 0.82 | 0.82 | 0.87 | 1.09 | 1.39 | 1.49 | Upgrade
|
| Current Ratio | 1.41 | 1.41 | 1.63 | 1.88 | 2.24 | 2.29 | Upgrade
|
| Return on Equity (ROE) | -881.26% | -881.26% | -36.06% | -85.96% | 5.45% | 19.50% | Upgrade
|
| Return on Assets (ROA) | 6.24% | 6.24% | 4.66% | 3.23% | 3.41% | 2.37% | Upgrade
|
| Return on Capital (ROIC) | 8.12% | 8.12% | 5.78% | 3.95% | 4.09% | 2.81% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.69% | 14.69% | 10.33% | 6.57% | 6.64% | 4.38% | Upgrade
|
| Earnings Yield | -4.31% | -4.76% | -4.51% | -43.12% | 1.48% | 13.50% | Upgrade
|
| FCF Yield | 8.66% | 9.57% | 16.06% | 5.41% | 26.68% | 47.01% | Upgrade
|
| Buyback Yield / Dilution | -75.42% | -75.42% | -16.69% | 0.58% | -1.95% | -12.72% | Upgrade
|
| Total Shareholder Return | -75.42% | -75.42% | -16.69% | 0.58% | -1.95% | -12.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.